3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
19
Glioma
12
Brain Neoplasms
8
Astrocytoma
7
Neoplasms
6
Neuroblastoma
5
Gliosarcoma
3
Diffuse Intrinsic Pontine Glioma
3
Spinal Cord Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Melanoma
2
Medulloblastoma
2
Wilms Tumor
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
pembrolizumab
55
Carboplatin
55
Pemetrexed
47
Cisplatin
37
Paclitaxel
21
Nivolumab
20
Docetaxel
19
durvalumab
18
osimertinib
14
Gemcitabine
14
Cetuximab
14
130-nm albumin-bound paclitaxel
14
atezolizumab
12
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
amivantamab
10
Radiotherapy
8
lazertinib
7
Taxes
7
Radiosurgery
7
alectinib
6
Ramucirumab
6
Observation
6
Ipilimumab
6
Bevacizumab
6
cemiplimab
5
Leucovorin
5
Fluorouracil
5
zimberelimab
4
entrectinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Temozolomide
×
30 days
×
Clear all
No trials found.